Skip to main content
Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design. Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, etc., providing excellent rationales for drug development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 14, Number 1, 2018

Articles

Free Content Graphical Abstracts
pp. i-iv(4)

Favourites:
ADD

Free Content Meet Our Regional Editor
pp. 1-1(1)
Author: Bhattacharjee, Apurba K.

Favourites:
ADD

Editorial

Favourites:
ADD
Favourites:
ADD

Review article

Quantitative Structure-Activity Relationships of Aquatic Narcosis: A Review
pp. 7-28(22)
Authors: Adhikari, Chandana; Mishra, Bijay k.

Favourites:
ADD

Research article

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Molecular Docking Studies Applied to a Dataset of Cruzain Inhibitors
pp. 68-78(11)
Authors: da Silva-Junior, Edeildo F.; Barcellos Franca, Paulo Henrique; Ribeiro, Frederico Favaro; Bezerra Mendonca-Junior, Francisco Jaime; Scotti, Luciana; Scotti, Marcus Tullius; de Aquino, Thiago Mendonca; de Araujo-Junior, Joao Xavier

Favourites:
ADD
Favourites:
ADD

Design, Synthesis, and Biological Evaluation of Vanillin Hydroxamic Acid Derivatives as Novel Peptide Deformylase Inhibitors
pp. 95-101(7)
Authors: Gao, Jian; Qiu, Shengzhi; Liang, Li; Hao, Zhixiang; Zhou, Qianqian; Wang, Fanfan; Mou, Jie; Lin, Qisi

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content